Zomedica Corp. (ZOM)
USD 0.1
(-0.21%)
USD 0.1
(-0.21%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -31.59 Million USD | -44.1% |
| 2023 | -21.92 Million USD | -2.57% |
| 2022 | -21.37 Million USD | -27.49% |
| 2021 | -16.76 Million USD | 15.26% |
| 2020 | -19.78 Million USD | -19.33% |
| 2019 | -16.57 Million USD | -105.09% |
| 2018 | -8.08 Million USD | -34.77% |
| 2017 | -5.99 Million USD | -162.15% |
| 2016 | -2.28 Million USD | -5295.54% |
| 2015 | -42.4 Thousand USD | 45.27% |
| 2014 | -77.49 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | -5.94 Million USD | 11.78% |
| 2024 Q4 | -11.38 Million USD | -91.48% |
| 2024 Q1 | -7.51 Million USD | -46.26% |
| 2024 Q2 | -6.74 Million USD | 10.25% |
| 2024 FY | -31.59 Million USD | -44.1% |
| 2023 FY | -21.92 Million USD | -2.57% |
| 2023 Q3 | -6.59 Million USD | -12.11% |
| 2023 Q2 | -5.88 Million USD | -36.3% |
| 2023 Q1 | -4.31 Million USD | 25.09% |
| 2023 Q4 | -5.13 Million USD | 22.09% |
| 2022 Q2 | -5.32 Million USD | -37.61% |
| 2022 Q4 | -5.75 Million USD | 10.13% |
| 2022 FY | -21.37 Million USD | -27.49% |
| 2022 Q1 | -3.87 Million USD | 6.2% |
| 2022 Q3 | -6.4 Million USD | -20.26% |
| 2021 FY | -16.76 Million USD | 15.26% |
| 2021 Q2 | -5.3 Million USD | -127.23% |
| 2021 Q1 | -2.33 Million USD | 18.33% |
| 2021 Q4 | -4.12 Million USD | 17.44% |
| 2021 Q3 | -5 Million USD | 5.7% |
| 2020 Q2 | -2.39 Million USD | 79.55% |
| 2020 FY | -19.78 Million USD | -19.33% |
| 2020 Q4 | -2.85 Million USD | -0.45% |
| 2020 Q3 | -2.84 Million USD | -18.96% |
| 2020 Q1 | -11.69 Million USD | -38.91% |
| 2019 Q1 | -2.16 Million USD | 15.27% |
| 2019 FY | -16.57 Million USD | -105.09% |
| 2019 Q4 | -8.41 Million USD | -356.18% |
| 2019 Q3 | -1.84 Million USD | 55.52% |
| 2019 Q2 | -4.14 Million USD | -91.15% |
| 2018 Q1 | -1.84 Million USD | 37.72% |
| 2018 Q3 | -2.08 Million USD | -31.11% |
| 2018 Q4 | -2.56 Million USD | -22.77% |
| 2018 FY | -8.08 Million USD | -34.77% |
| 2018 Q2 | -1.59 Million USD | 13.82% |
| 2017 Q1 | -15.55 Thousand USD | 34.84% |
| 2017 Q3 | -1.03 Million USD | 2.57% |
| 2017 Q2 | -1.06 Million USD | -6759.99% |
| 2017 Q4 | -2.96 Million USD | -185.06% |
| 2017 FY | -5.99 Million USD | -162.15% |
| 2016 Q1 | -15.6 Thousand USD | -77.77% |
| 2016 Q4 | -23.87 Thousand USD | -400.88% |
| 2016 Q3 | -4766.69 USD | 57.23% |
| 2016 FY | -2.28 Million USD | -5295.54% |
| 2016 Q2 | -11.14 Thousand USD | 28.59% |
| 2015 Q2 | -7895.27 USD | -34.8% |
| 2015 Q4 | -8779.16 USD | 20.97% |
| 2015 Q3 | -11.1 Thousand USD | -40.7% |
| 2015 FY | -42.4 Thousand USD | 45.27% |
| 2015 Q1 | -5857.02 USD | 88.46% |
| 2014 Q2 | -14.5 Thousand USD | 0.0% |
| 2014 Q4 | -50.74 Thousand USD | -640.24% |
| 2014 FY | -77.49 Thousand USD | 0.0% |
| 2014 Q3 | -6855.44 USD | 52.75% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| China Pharma Holdings, Inc. | -2.75 Million USD | -1048.04% |
| cbdMD, Inc. | -9.26 Million USD | -240.852% |
| cbdMD, Inc. | -9.26 Million USD | -240.852% |